SCHEMBL4535685

SCHEMBL4535685

O=C(O)CNC(=O)c1cc(Br)c(OCc2cc(Cl)cc(NC3CCC3)c2)c(Br)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRA P10827 5/20 0.38
THRB P10828 5/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
DHODH Q02127 2/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
PTPN1 P18031 3/20 0.35
TAOK1 Q7L7X3 1/20 0.35
TAOK3 Q9H2K8 1/20 0.35
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ENPP2 Q13822 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926882 0.91 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DTAOK1
SCHEMBL4931128 0.89 MEN1 (0.37) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4360211 0.89 MEN1 (0.39) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4351071 0.87 THRA (0.46) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4934191 0.87 EGLN1 (0.36) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4929949 0.87 THRA (0.41) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL5718186 0.87 PTGDR (0.34) THRATHRBMEN1KMT2APDE4A
SCHEMBL5718319 0.84 THRB (0.51) THRATHRBDHODHPTPN1ENPP2
SCHEMBL4926195 0.84 CACNA1I (0.39) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4929610 0.83 THRA (0.40) THRATHRBMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885MEN1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.